National Cancer Institute

February 19, 2015February 19, 2015

Implementing Lung-RADS Guidelines May Result in More Effective Lung Cancer Screening

Lung cancer News, News

A recently published retrospective study conducted by a team of investigators from the National Cancer Institute (NCI), Houston Methodist Hospital, Houston, Texas, and other well-established institutions conducting oncology research, showed ... Read more

November 13, 2014November 18, 2014

Smoking Cigars Or Cigarettes Is Equally Harmful, Study Says

News

A new study titled “Biomarkers of Exposure among U.S. Cigar Smokers: An Analysis of 1999–2012 National Health and Nutrition Examination Survey (NHANES) Data“, published in the journal Cancer Epidemiology, Biomarkers & ... Read more

September 29, 2014September 29, 2014

NCI/FDA Lung Cancer Workshop Leads To LUNG-MAP And ALCHEMIST Clinical Trials

Lung cancer News, News

Two of the most innovative lung cancer focused clinical studies launched recently, the Lung Cancer Master Protocol (Lung-MAP) and the Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST), ... Read more

September 17, 2014September 17, 2014

NIC Reassures Benefits of Lung Cancer Screening in Senior Patients in Response to Medicare Coverage Questions

Lung cancer News, News

A new lung cancer test may benefit heavy smokers older than 65 years, as demonstrated by a study reanalyzed by investigators at the National Cancer Institute, as Medicare is raising questions about the ... Read more

September 16, 2014September 16, 2014

Treatment For Lung Cancer May Depend On Your DNA

Lung cancer News, News

The Northside Hospital Cancer Institute (NHCI), Atlanta, has announced it will participate in a unique National Cancer Institute clinical collaboration to treat lung cancer based on a patient’s genetic profile, ... Read more

August 19, 2014August 19, 2014

New National Cancer Institute Trial Focuses On Preventing Recurrence in Two Types of Lung Cancer

Lung cancer News, News

A new trial promoted by the National Cancer Institute will evaluate whether targeting erlotinib and crizotinib drugs used against epidermal growth factor receptor (EGFR) and anapestic lymphoma kinase (ALK) gene changes in lung ... Read more